TRIMming p53 for ubiquitination

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 28, 2009, Pages 11431-11432

  Taia, Elizabeth ^a   Benchimolb, Samuel ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b YORK UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HYBRID PROTEIN; PROTEIN MDM2; PROTEIN P53; PROTEIN TRIM24; RETINOIC ACID RECEPTOR; SHORT HAIRPIN RNA; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN PROTEIN LIGASE COP1; UNCLASSIFIED DRUG;

APOPTOSIS; CANCER GROWTH; CANCER INCIDENCE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CHROMATIN; DNA BINDING; GENETIC CONSERVATION; HOMOZYGOSITY; HUMAN; LIVER CARCINOMA; LIVER CELL CARCINOMA; MASS SPECTROMETRY; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PROCESSING; PROTEIN PURIFICATION; PROTEIN STABILITY; PROTEIN TARGETING; RNA INTERFERENCE; UBIQUITINATION;

PROTO-ONCOGENE PROTEINS C-MDM2; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 67650886073     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0905997106     Document Type: Note

References (18)

1. Vousden KH, Prives C (2009) Blinded by the light: The growing complexity of p53. Cell 137:413-431.
2. Kruse JP, Gu W (2009) Modes of p53 regulation. Cell 137:609-622.
3. Allton K, et al. (2009) Trim24 targets endogenous p53 for degradation. Proc Natl Acad Sci USA 106:11612-11616.
4. Nisole S, Stoye JP, Saib A (2005) TRIM family proteins: Retroviral restriction and antiviral defense. Nat Rev Microbiol 3:799-808.
5. Sardiello M, Cairo S, Fontanella B, Ballabio A, Meroni G (2008) Genomic analysis of the TRIM family reveals two groups of genes with distinct evolutionary properties. BMC Evol Biol 8:255.
6. Jones SN, Roe AE, Donehower LA, Bradley A (1995) Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 378:206-208.
7. Montes de Oca Luna R, Wagner DS, Lozano G (1995) Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378:203-206.
8. Khetchoumian K, et al. (2007) Loss of Trim24 (Tif1α) gene function confers oncogenic activity to retinoic acid receptor α. Nat Genet 39:1500-1506.
9. Xue W, et al. (2007) Senescence and tumor clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445:656-660.
10. Leng RP, et al. (2003) Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation. Cell 112:779-791.
11. Dornan D, et al. (2004) The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature 429:86 - 92.
12. Chen D, et al. (2005) ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor. Cell 121:1071-1083.
13. Rajendra R, et al. (2004) Topors functions as an E3 ubiquitin ligase with specific E2 enzymes and ubiquitinates p53. J Biol Chem 279:36440-36444.
14. Yang W, et al. (2007) CARPs are ubiquitin ligases that promote MDM2-independent p53 and phosphop53ser20 degradation. J Biol Chem 282:3273-3281.
15. Yamasaki S, et al. (2007) Cytoplasmic destruction of p53 by the endoplasmic reticulum-resident ubiquitin ligase Synoviolin. EMBO J 26:113-122.
16. Sheng Y, et al. (2008) Molecular basis of Pirh2-mediated p53 ubiquitylation. Nat Struct Mol Biol 15:1334-1342.
17. Dornan D, et al. (2006)ATMengages autodegradation of the E3 ubiquitin ligase COP1 after DNA damage. Science 313:1122-1126.
18. Duan S, et al. (2007) Phosphorylation of Pirh2 by calmodulin-dependent kinase II impairs its ability to ubiquitinate p53. EMBO J 26:3062-3074.